Revenue
2016
2017
2018
2021
2022
2023
2024
2025
Kazia Therapeutics Ltd (KZIA)
Price$12.31Cached quote
Net income
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2016
2017
Total cash / debt
CashTotal debt
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $42,000 | $2.3M | $0 | $0 | $15.2M | — | — | $119,000 | $249,000 | $406,000 |
| Research & development | $7.3M | $17.4M | $15.6M | $20.2M | $14.5M | $9.5M | $6.5M | $9.8M | $11.1M | $9.9M |
| Operating expenses | $14.3M | $30.8M | $24.1M | $25.4M | — | — | — | — | — | — |
| Operating income | −$14.2M | −$28.5M | −$24.1M | −$25.4M | — | — | — | — | — | — |
| Operating margin | −33,850.00% | −1,233.19% | — | — | — | — | — | — | — | — |
| EBITDA | −$13.3M | −$26.6M | −$22.3M | −$23.5M | — | — | — | — | — | — |
| EBITDA margin | −31,626.19% | −1,152.21% | — | — | — | — | — | — | — | — |
| Net income | −$20.7M | −$26.8M | −$20.5M | −$25.0M | −$8.4M | −$12.5M | −$10.3M | −$6.0M | −$10.7M | −$12.2M |
| Net profit margin | −49,290.48% | −1,160.23% | — | — | −55.46% | — | — | −5,074.79% | −4,285.14% | −2,993.84% |
| Basic EPSper basic share | -A$0.04 | -A$0.10 | -A$0.11 | -A$0.19 | -A$0.07 | -A$0.17 | -A$0.18 | -A$0.12 | -A$0.02 | -A$0.03 |
| Diluted EPSper diluted share | -A$0.04 | -A$0.10 | -A$0.11 | -A$0.19 | -A$0.07 | -A$0.17 | -A$0.18 | -A$0.12 | -A$0.02 | -A$0.03 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Boxer Capital Management, LLC | 560K |
FLPUTNAM INVESTMENT MANAGEMENT CO | 414.96K |
Bleichroeder LP | 400K |
Ikarian Capital, LLC | 396.2K |
Dauntless Investment Group, LLC | 354.21K |
Stonepine Capital Management, LLC | 345.18K |
Point72 Asset Management, L.P. | 200.3K |
Ensign Peak Advisors, Inc | 110.78K |
MILLENNIUM MANAGEMENT LLC | 101.38K |
UBS Group AG | 81.09K |
J. Goldman & Co LP | 68.49K |
ADAR1 Capital Management, LLC | 61.55K |
JANE STREET GROUP, LLC | 57.14K |
BARCLAYS PLC | 57K |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 50.62K |
COOPERMAN LEON G | 50K |
Westside Investment Management, Inc. | 47.59K |
MORGAN STANLEY | 46.61K |
MARSHALL WACE, LLP | 44.23K |
XTX Topco Ltd | 31.19K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data